(Q51993553)

English

Emerging antidementia drugs: a preliminary ethical view.

scientific article published in June 1998

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9625200

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/9625200

title

Emerging antidementia drugs: a preliminary ethical view. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9625200

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/9625200

author name string

Post SG

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9625200

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/9625200

Whitehouse PJ

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9625200

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/9625200

language of work or name

English

0 references

publication date

1 June 1998

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9625200

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/9625200

published in

Journal of the American Geriatrics Society

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9625200

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/9625200

volume

46

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9625200

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/9625200

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9625200

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/9625200

page(s)

784-787

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9625200

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/9625200

cites work

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB03819.X

retrieved

21 January 2018

Drug treatments for Alzheimer's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB03819.X

retrieved

21 January 2018

Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB03819.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1532-5415.1998.TB03819.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9625200

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/9625200

PubMed publication ID

9625200

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9625200

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/9625200

(Q51993553)

Emerging antidementia drugs: a preliminary ethical view.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)